Local at heart, global in action: The Cryoviva Singapore approach
Local at heart, global in action: The Cryoviva Singapore approach This year, 2023, Cryoviva Singapore will complete 9 years of operations in Singapore, our own little red dot. It has…
Upgrade to AXP®II System
Singapore family cord blood bank Cryoviva upgrades to AXP® II System for cord blood processing Widely recognised as a benchmark for volume reduction of cord blood processing, this FDA-cleared, functionally…
KKH Autism Trial
Cryoviva Singapore contributes to the first-of-its-kind clinical trial in Singapore run by KKH for the treatment of autism (ASD) through autologous umbilical cordblood (AUCB) reinfusion.
Cryoviva Singapore named ‘Biotechnology Company of the Year 2021’
Cryoviva Singapore named ‘Biotechnology Company of the Year 2021’ Singapore, January 10, 2022: Family cord blood bank Cryoviva Singapore is pleased to announce that it has been named the ‘Company…
In celebration of Cord Blood Awareness Month – THE STRAITS TIMES , 27th June 2018, Wednesday
In celebration of Cord Blood Awareness Month – THE STRAITS TIMES , 27th June 2018, Wednesday
Singapore Cord Blood Bank Cryoviva establishes Footprint in UAE
Singapore cord blood bank Cryoviva establishes footprint in UAE Company plans to build on its strong foundation in Singapore to help families in Dubai and the other Emirates in the…
